British Study: Ozempic Linked With Lower Dementia Risk

DIABETES - JAKARTA - Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower risk of cognitive problems, according to an observational study published by researchers at Oxford University.

The study, published in the Lancet's clinical medicine journal on Thursday, explored more than 100 million medical records of U.S. patients to see if Ozempic increased the risk of several neurological and psychiatric conditions in the first year of use compared with three common antidiabetic drugs.